Urinary Slings Market in the US 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Indications for Use of Urinary Slings
06.1 Urinary Incontinence
06.2 Types of Urinary Incontinence
06.2.1 Stress Incontinence
06.2.2 Urge Incontinence
06.2.3 Mixed Incontinence
06.2.4 Functional Incontinence
06.2.5 Overflow Incontinence
06.3 Pelvic Organ Prolapse
06.4 Overactive Bladder
06.5 Treatment Techniques for Urinary Incontinence
07. SUI
07.1 Patient Profile
07.2 Treatment Comparison
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by Type
09.1 Vaginal Slings
09.2 Male Slings
09.3 Vaginal Slings Market in US
09.3.1 Market Size and Forecast
09.4 Male Slings Market in US
09.4.1 Market Size and Forecast
10. Vaginal Slings Market in US
10.1 Mid-Urethral Slings
10.2 Single-incision Slings
10.3 TOT Slings Market in US
10.3.1 Market Size and Forecast
10.4 TVT Slings Market in US
10.4.1 Market Size and Forecast
10.5 Single-incision Slings Market in US
10.5.1 Market Size and Forecast
11. Male Slings Market in the US
11.1.1 Market Size and Forecast
12. Reimbursement Scenario
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.2 Market Share Analysis 2014
20.3 Other Prominent Vendors
21. Key Vendor Analysis
21.1 American Medical Systems
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Key Brands
21.1.4 Therapeutic Areas
21.1.5 Geographical Segmentation
21.1.6 Business Strategy
21.1.7 Recent Developments
21.1.8 SWOT Analysis
21.2 Boston Scientific
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Key Products
21.2.4 Key Products in Cardiovascular Segment
21.2.5 Key Products in MedSurg Segment
21.2.6 Key Products in Rhythm Management Segment
21.2.7 Business Segmentation by Revenue 2013
21.2.8 Business Segmentation by Revenue 2012 and 2013
21.2.9 Geographical Segmentation by Revenue 2013
21.2.10 Business Strategy
21.2.11 Recent Developments
21.2.12 SWOT Analysis
21.3 Coloplast
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2014
21.3.4 Business Segmentation by Revenue 2013 and 2014
21.3.5 Geographical Segmentation by Revenue 2014
21.3.6 Business Strategy
21.3.7 Key Developments
21.3.8 SWOT Analysis
21.4 C. R. Bard
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Product Segmentation by Revenue 2013
21.4.4 Product Segmentation by Revenue 2012 and 2013
21.4.5 Geographical Segmentation by Revenue 2013
21.4.6 Business Strategy
21.4.7 Recent Developments
21.4.8 SWOT Analysis
21.5 Johnson & Johnson
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2013
21.5.4 Business Segmentation by Revenue 2012 and 2013
21.5.5 Geographical Segmentation by Revenue 2013
21.5.6 Business Strategy
21.5.7 Recent Developments
21.5.8 SWOT Analysis
22. Other Reports in this Series